Back
Akebia Therapeutics Vs. Kyndryl Holdings Industry Stock Comparison
Buy
59
AKBA
Akebia Therapeutics
Last Price:
1.85
Seasonality Move:
42.93%
Sell
22
KD
Kyndryl Holdings
Last Price:
32.90
Seasonality Move:
21.65%
Buy
59
Akebia Therapeutics (AKBA)
is a Buy
Is Akebia Therapeutics a Buy, Sell or Hold?
- The current Akebia Therapeutics [AKBA] share price is $1.82. The Score for AKBA is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- AKBA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
Kyndryl Holdings (KD)
is a Sell
Is Kyndryl Holdings a Buy, Sell or Hold?
- The current Kyndryl Holdings [KD] share price is $32.49. The Score for KD is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- KD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKBA Stock Price Chart
What is Akebia Therapeutics's stock price today?
-
The Akebia Therapeutics share price today is $1.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKBA is experiencing buying pressure, which is a positive indicator for future bullish movement.
KD Stock Price Chart
What is Kyndryl Holdings's stock price today?
-
The Kyndryl Holdings share price today is $32.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KD is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKBA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 57.25 | Buy |
| Chaikin Money Flow: | 1076435 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.58 - 1.92) | Buy |
| Bollinger Bands (100): | (1.21 - 1.67) | Buy |
KD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.52 | Buy |
| Relative Strength Index (14 RSI): | 83.94 | Buy |
| Chaikin Money Flow: | 4050180 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.38 - 28.4) | Buy |
| Bollinger Bands (100): | (22.65 - 26.71) | Buy |
AKBA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.84 | Sell |
| 20-day SMA: | 1.81 | Buy |
| 50-day SMA: | 1.54 | Buy |
| 200-day SMA: | 1.41 | Buy |
| 8-day EMA: | 1.83 | Sell |
| 20-day EMA: | 1.78 | Buy |
| 50-day EMA: | 1.62 | Buy |
| 200-day EMA: | 1.4 | Buy |
KD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.77 | Buy |
| 20-day SMA: | 26.27 | Buy |
| 50-day SMA: | 24.78 | Buy |
| 200-day SMA: | 23.96 | Buy |
| 8-day EMA: | 28.86 | Buy |
| 20-day EMA: | 27.1 | Buy |
| 50-day EMA: | 25.54 | Buy |
| 200-day EMA: | 23.47 | Buy |
Akebia Therapeutics Earnings Growth & AKBA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.07 per share.
Kyndryl Holdings Earnings Growth & KD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.37 per share, and an increase next year of $1.26 per share.
Akebia Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kyndryl Holdings Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||